Table 1 A summary of the clinical... | American Society of Hematology

Table 1

A summary of the clinical features of the lymphoma patients and the corresponding immunophenotypes

Individual	Age of onset (y)	Sites of involvement	Diagnosis	Immunophenotype
Individual	Age of onset (y)	Sites of involvement	Diagnosis	CD20	CD30	CD10	CD23	MIB1	IRF4/ MUM1	BCL2	BCL6	PAX5	OCT2	BOB1	LMP-1
III-1	35	Mediastinal tumor	PMBCL stage IA	+	+	—	—	∼50%	±	±	+	+	+	+	—
III-2	46	Mediastinal tumor; cervical, supraclavicular, and axillary lymph nodes	PMBCL stage IIIB	+	+	—	—	∼50%	+	±	+	+	+	+	—
III-3	30	Mediastinal tumor, minor liver involvement	PMBCL stage IVB	+	+	—	—	∼50%	+	±	+	+	+	+	—
III-6	53	Tumor between urinary bladder and uterus relapse: intestine and axillary lymph nodes	DLBCL stage IV	+	+	—	—	∼97%	++	—	+	+	+	+	—

Individual	Age of onset (y)	Sites of involvement	Diagnosis	Immunophenotype
Individual	Age of onset (y)	Sites of involvement	Diagnosis	CD20	CD30	CD10	CD23	MIB1	IRF4/ MUM1	BCL2	BCL6	PAX5	OCT2	BOB1	LMP-1
III-1	35	Mediastinal tumor	PMBCL stage IA	+	+	—	—	∼50%	±	±	+	+	+	+	—
III-2	46	Mediastinal tumor; cervical, supraclavicular, and axillary lymph nodes	PMBCL stage IIIB	+	+	—	—	∼50%	+	±	+	+	+	+	—
III-3	30	Mediastinal tumor, minor liver involvement	PMBCL stage IVB	+	+	—	—	∼50%	+	±	+	+	+	+	—
III-6	53	Tumor between urinary bladder and uterus relapse: intestine and axillary lymph nodes	DLBCL stage IV	+	+	—	—	∼97%	++	—	+	+	+	+	—

+, ++, positive staining; ±, moderate staining; −, negative staining.